Wholesaler Dropped As Lead In ADHD Drug Antitrust Suit

Law360 (July 8, 2020, 5:25 PM EDT) -- A Massachusetts federal judge disqualified wholesaler Rochester Drug Co-Operative from leading a class of direct purchasers accusing pharmaceutical companies Actavis and Shire of conspiring to delay sales of a generic version of the ADHD medication Intuniv.

The drug wholesaler's separate Chapter 11 bankruptcy filing in which Actavis and Shire are creditors creates a clear conflict of interest, U.S. District Judge Allison Burroughs ruled on Wednesday. Rochester filed for bankruptcy roughly 11 months after the Department of Justice filed criminal charges alleging it sold prescription opioids to pharmacies despite clear evidence the drugs were being diverted for illicit use.

Despite disqualifying Rochester...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!